Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder

Journal of Clinical Psychiatry

Volumn 63, Issue 1, 2002, Pages 31-37

  Versiani, Marcio ^a   Cassano, Giovanni ^a   Perugi, Giulio ^a   Benedetti, Alessandra ^a   Mastalli, Luigia ^a   Nardi, Antonio ^a   Savino, Mario ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPRAZOLAM; CITALOPRAM; DESIPRAMINE; FLUOXETINE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PLACEBO; REBOXETINE; SERTRALINE; VENLAFAXINE;

ADULT; AGED; AGORAPHOBIA; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INSOMNIA; MALE; MULTICENTER STUDY; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SYNCOPE; TREMOR; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0036154641     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0107     Document Type: Article

References (46)

1. Lifetime prevalence of panic states
2. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States
3. Panic and panic disorder in the United States
4. Panic disorder as a chronic illness
5. A model of panic and agoraphobic development
6. Toward an integrated neurobiology of panic disorder
7. The neurobiology of anxiety disorders: Brain circuits in panic disorder
8. The role of SSRIs in panic disorder
9. The neurobiological basis of anxiety and fear: Circuits, mechanisms, and neurochemical interactions
10. The Galway study of panic disorder 1, clomipramine and lofepramine in DSM-III-R panic disorder: A placebo controlled trial
11. Preliminary report: Placebo-controlled, double-blind study of the clinical effects of desipramine in panic disorder
12. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorders: A double-blind comparative study with fluvoxamine and maprotiline
13. Reboxetine: Additional benefits to the depressed patient
14. Reboxetine: A review of antidepressant tolerability
15. Diagnosis and psychiatry: Examination of the psychiatric patient
16. Brief standard self-rating for phobic patients
17. A rating scale for depression
18. The Hopkins Symptom Checklist (HSCL)
19. Dosage Record and Treatment Emergent Symptom Scale
20. Alprazolam in the treatment of panic disorders
21. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder
22. Drug treatment of panic disorder: Comparative efficacy of alprazolam, imipramine and placebo
23. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder
24. Diazepam versus alprazolam for the treatment of panic disorder
25. Noradrenergic function and the mechanism of action of antianxiety treatment, 1: The effect of long-term alprazolam treatment
26. Alprazolam in panic disorder and agoraphobia: Results from a multicentre trial, 1: Efficacy in short-term treatment
27. Behaviour therapy, supportive psychotherapy, imipramine and phobias
28. Treatment of phobias, 1: Comparison of imipramine hydrochloride and placebo
29. Treatment of endogenous anxiety with phobias, hysterical and hypochondrical symptoms
30. Clomipramine for panic disorder, 1: The first 10 weeks of a long-term comparison with imipramine
31. Superiority of clomipramine over imipramine in the treatment of panic disorder: A placebo-controlled trial
32. Desipramine treatment in panic disorder
33. Moclobemide and fluoxetine for panic disorder
34. The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder
35. Paroxetine in the treatment of panic disorder: A randomised, double-blind, placebo-controlled study
36. Sertraline in the treatment of panic disorder: A multi-site, double-blind, placebo-controlled, fixed-dose investigation
37. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder
38. An open trial of fluoxetine in the treatment of panic attacks
39. Venlafaxine treatment of panic disorder: A case series
40. Venlafaxine for panic disorder: Results from a double-blind, placebo-controlled study
41. Low-dose venlafaxine treatment in panic disorder